A 4-year-old girl with diphtheria is on day 5 of antitoxin and IV penicillin therapy. She remains afebrile and the pharyngeal membrane has begun to separate. However, her mother reports that the child has developed weakness in both legs over the past 24 hours and is unable to climb stairs. On neurological examination, you note symmetrical lower limb weakness (grade 3/5) with diminished reflexes. What is the most appropriate next step in management?

Explanation

## Clinical Scenario Analysis This child has developed **post-diphtheric neuropathy**, a well-recognized complication occurring in the 2nd–3rd week of illness. The symmetrical lower limb weakness with diminished reflexes is pathognomonic for this complication. ## Pathophysiology of Diphtheric Neuropathy **Key Point:** Diphtheric neuropathy is caused by **diphtheria toxin-mediated demyelination**, not by ongoing bacterial infection or inflammation. It occurs despite appropriate antibiotic and antitoxin therapy because the toxin has already caused irreversible damage to myelin. **Mnemonic:** **DIPHTHERIA NEURO** — Demyelinating, Irreversible, Post-toxin, Happens despite therapy, Toxin-mediated, Hyporeflexia, Electrolyte monitoring, Recovery is slow, Respiratory involvement is the danger, Intensive supportive care. ## Why This Is NOT Meningitis | Feature | Diphtheric Neuropathy | Meningitis | |---------|----------------------|------------|| | **Onset** | Days 5–21 of illness | Acute, within 48 hrs | | **Pattern** | Symmetrical, ascending | Variable, often meningeal signs | | **CSF** | Normal or mildly elevated protein | High protein, pleocytosis | | **Fever** | Absent (child is afebrile) | Present | | **Reflexes** | Diminished/absent | Normal or hyperactive | This child is **afebrile** — meningitis is unlikely. Lumbar puncture is not indicated and may delay supportive care. ## Management of Diphtheric Neuropathy ```mermaid flowchart TD A[Diphtheric neuropathy diagnosed]:::outcome --> B[Continue antibiotics & antitoxin]:::action B --> C[Assess respiratory muscles]:::decision C -->|Intact| D[Monitor for progression]:::action C -->|Weak| E[Prepare for respiratory support]:::action D --> F[Supportive care: nutrition, PT/OT]:::action E --> F F --> G[Recovery over weeks to months]:::outcome ``` **High-Yield:** Management is **supportive**, not curative. Antitoxin and antibiotics have already been given; they cannot reverse toxin-induced demyelination. ## Monitoring Priorities 1. **Respiratory function**: Bulbar and respiratory muscle involvement is the life-threatening complication. Monitor vital capacity, ability to swallow, and cough reflex. 2. **Nutritional support**: Nasogastric feeding if bulbar weakness develops. 3. **Physical therapy**: Passive range of motion and positioning to prevent contractures. 4. **Electrolyte monitoring**: Ensure adequate sodium, potassium, and magnesium for neuromuscular function. **Clinical Pearl:** Most children recover completely over 2–3 months, but respiratory involvement can be fatal. The focus is on preventing complications, not treating the neuropathy itself. [cite:Park 26e Ch 8; Harrison 21e Ch 139]